Restless leg syndrome (also referred to as RLS or Willis Ekborn Disease) is characterized by painful or uncomfortable sensations (dysesthesias or paresthesias) in the legs. Sensations are commonly described as throbbing, buzzing or creepy-crawly pains. Individuals with restless legs syndrome also describe an insatiable urge to move the legs. Symptoms of restless legs syndrome arise while the patient is at rest, and can become more severe at night while the patient is sleeping or toward the end of the patient’s wake period. Because of this, sleep is chronically disturbed and quality of life may suffer.
A case study outlined in the McDonagh, et al., 2007 paper, “Restless legs syndrome in patients with chronic venous disorders: an untold story” presents a strong correlation between restless legs syndrome and CVI (the latter causing the former). In the case-control study, patients suffering from both conditions experienced more prevalent cramping.
Restless legs syndrome is twice as likely to affect women (especially over the age of 50) than men and may be accompanied by Periodic Limb Movement Disorder, which causes the patient to jerk their legs or arms while sleeping. Genetic predisposition and pregnancy may also increase ones odds of developing restless legs syndrome as a secondary condition to chronic venous insufficiency.
If a patient is diagnosed with chronic venous insufficiency, endovenous ablation and ultrasound guided sclerotherapy that targets the CVI condition is the most effective way to treat restless legs.
Clint Hayes and John Kingsley, et al., published a paper in 2008 in the journal, Phlebology entitled, “The effect of endovenous laser ablation on restless legs syndrome”. The paper revealed that 53 percent of participants with ultrasound-diagnosed CVI reported a reduction in overall restless legs symptoms and 31 percent of participants reported complete relief.